COVID-19 Vaccine Distribution Information for the Duke Community
Dear Duke Health and Duke University colleagues and staff: The FDA is planning to review the interim safety and efficacy data for the Pfizer/BioNTech COVID-19 vaccine on December 10th and the Moderna vaccine on December 17th as part of the process to consider COVID-19 vaccines for an emergency use authorization.
Vaccine Distribution: Opportunities and Pitfalls
Four Duke scholars examine logistics, vaccinating children and ensuring poor nations aren't left out
Gut Microbiome Snapshot Could Reveal Chemical Exposures in Children
Dec 03, 2020
Pratt School of Engineering
Some Triangle Hospitals Expecting to Have a COVID-19 Vaccine in as Few as 2 Weeks
Features comments by Dr. Joseph Rogers, chief medical officer for Duke Health
Dec 02, 2020
WNCN-Raleigh
Rapid Testing for Children Barrels Ahead, Despite a Lack of Data
Quotes Dr. Ibukun Akinboyo, a pediatrician and infectious disease expert at Duke
Dec 02, 2020
MSN News, New York Times
Sign Over I-40 in Durham Could Damage Public Trust About Vaccine Process, Expert Says
Features comments by Thomas Denny, chief operating officer of Duke’s Human Vaccine Institute
Dec 02, 2020
MSN Health, News & Observer
‘All Hands on Deck’: How Duke and AI for Health Raced to Create a COVID-19 Solution for Patients
Featuring the work and comments of assistant professor of biomedical sciences Amanda Randles and her team at Duke
Dec 02, 2020
Microsoft’s The AI Blog
Barr Makes Durham a Special Counsel in a Bid to Entrench Scrutiny of the Russia Inquiry
Quotes Samuel Buell, a Duke University law professor and former federal prosecutor
Dec 02, 2020
New York Times
Texas Prepares for COVID-19 Vaccine
Interview with Dr. Mark McClellan, director of the Duke-Margolis Center for Health Policy
Dec 02, 2020
YouTube, KVUE-Austin